159 related articles for article (PubMed ID: 21622244)
1. Endothelial dysfunction in hypertension: the role of arginase.
Michell DL; Andrews KL; Chin-Dusting JP
Front Biosci (Schol Ed); 2011 Jun; 3(3):946-60. PubMed ID: 21622244
[TBL] [Abstract][Full Text] [Related]
2. Arginase upregulation and eNOS uncoupling contribute to impaired endothelium-dependent vasodilation in a rat model of intrauterine growth restriction.
Grandvuillemin I; Buffat C; Boubred F; Lamy E; Fromonot J; Charpiot P; Simoncini S; Sabatier F; Dignat-George F; Peyter AC; Simeoni U; Yzydorczyk C
Am J Physiol Regul Integr Comp Physiol; 2018 Sep; 315(3):R509-R520. PubMed ID: 29741931
[TBL] [Abstract][Full Text] [Related]
3. Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Durante W; Johnson FK; Johnson RA
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639
[TBL] [Abstract][Full Text] [Related]
4. Arginase: A Multifaceted Enzyme Important in Health and Disease.
Caldwell RW; Rodriguez PC; Toque HA; Narayanan SP; Caldwell RB
Physiol Rev; 2018 Apr; 98(2):641-665. PubMed ID: 29412048
[TBL] [Abstract][Full Text] [Related]
5. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
Pernow J; Jung C
Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
[TBL] [Abstract][Full Text] [Related]
6. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
[TBL] [Abstract][Full Text] [Related]
7. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension.
Johnson FK; Johnson RA; Peyton KJ; Durante W
Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R1057-62. PubMed ID: 15591155
[TBL] [Abstract][Full Text] [Related]
8. Arginase and vascular aging.
Santhanam L; Christianson DW; Nyhan D; Berkowitz DE
J Appl Physiol (1985); 2008 Nov; 105(5):1632-42. PubMed ID: 18719233
[TBL] [Abstract][Full Text] [Related]
9. Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis.
Rabelo LA; Ferreira FO; Nunes-Souza V; da Fonseca LJ; Goulart MO
Oxid Med Cell Longev; 2015; 2015():924860. PubMed ID: 26064427
[TBL] [Abstract][Full Text] [Related]
10. [Disorders of endothelium-dependent vascular reactions and of the arginase and NO-synthase pathways of L-arginine metabolism in arterial hypertension].
Sahach VF; Baziliuk OV; Kotsiuruba AV; Buzhanevich OM
Fiziol Zh (1994); 2000; 46(3):3-13. PubMed ID: 11059380
[TBL] [Abstract][Full Text] [Related]
11. Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice.
Shin WS; Berkowitz DE; Ryoo SW
Exp Mol Med; 2012 Oct; 44(10):594-602. PubMed ID: 22854495
[TBL] [Abstract][Full Text] [Related]
12. Contribution of arginase activation to vascular dysfunction in cigarette smoking.
Sikka G; Pandey D; Bhuniya AK; Steppan J; Armstrong D; Santhanam L; Nyhan D; Berkowitz DE
Atherosclerosis; 2013 Nov; 231(1):91-4. PubMed ID: 24125417
[TBL] [Abstract][Full Text] [Related]
13. A Novel Arginase Inhibitor Derived from Scutellavia indica Restored Endothelial Function in ApoE-Null Mice Fed a High-Cholesterol Diet.
Hwang HM; Lee JH; Min BS; Jeon BH; Hoe KL; Kim YM; Ryoo S
J Pharmacol Exp Ther; 2015 Oct; 355(1):57-65. PubMed ID: 26265320
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles.
Thengchaisri N; Hein TW; Wang W; Xu X; Li Z; Fossum TW; Kuo L
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2035-42. PubMed ID: 16794224
[TBL] [Abstract][Full Text] [Related]
15. Impaired L-arginine uptake but not arginase contributes to endothelial dysfunction in rats with chronic kidney disease.
Martens CR; Kuczmarski JM; Lennon-Edwards S; Edwards DG
J Cardiovasc Pharmacol; 2014 Jan; 63(1):40-8. PubMed ID: 24084210
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles.
Zhang C; Hein TW; Wang W; Miller MW; Fossum TW; McDonald MM; Humphrey JD; Kuo L
Hypertension; 2004 Dec; 44(6):935-43. PubMed ID: 15492130
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension.
Bagnost T; Ma L; da Silva RF; Rezakhaniha R; Houdayer C; Stergiopulos N; André C; Guillaume Y; Berthelot A; Demougeot C
Cardiovasc Res; 2010 Aug; 87(3):569-77. PubMed ID: 20219858
[TBL] [Abstract][Full Text] [Related]
18. The Mechanisms of L-Arginine Metabolism Disorder in Endothelial Cells.
Mammedova JT; Sokolov AV; Freidlin IS; Starikova EA
Biochemistry (Mosc); 2021 Feb; 86(2):146-155. PubMed ID: 33832413
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptor.
Nelin LD; Chicoine LG; Reber KM; English BK; Young TL; Liu Y
Am J Respir Cell Mol Biol; 2005 Oct; 33(4):394-401. PubMed ID: 15994432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
